Elevance Health Statistics

Total Valuation

Elevance Health has a market cap or net worth of GBP 72.50 billion. The enterprise value is 90.50 billion.

Market Cap	72.50B
Enterprise Value	90.50B

Important Dates

The last earnings date was Wednesday, April 16, 2025.

Earnings Date	Apr 16, 2025
Ex-Dividend Date	Mar 10, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-1.90%
Shares Change (QoQ)	-0.86%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	225.89M

Valuation Ratios

The trailing PE ratio is 15.18.

PE Ratio	15.18
Forward PE	n/a
PS Ratio	0.51
PB Ratio	2.19
P/TBV Ratio	96.15
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.94, with an EV/FCF ratio of 24.89.

EV / Earnings	18.95
EV / Sales	0.68
EV / EBITDA	11.94
EV / EBIT	13.04
EV / FCF	24.89

Financial Position

The company has a current ratio of 1.45, with a Debt / Equity ratio of 0.77.

Current Ratio	1.45
Quick Ratio	1.32
Debt / Equity	0.77
Debt / EBITDA	3.19
Debt / FCF	7.04
Interest Coverage	7.76

Financial Efficiency

Return on equity (ROE) is 14.77% and return on invested capital (ROIC) is 8.28%.

Return on Equity (ROE)	14.77%
Return on Assets (ROA)	5.09%
Return on Invested Capital (ROIC)	8.28%
Return on Capital Employed (ROCE)	12.05%
Revenue Per Employee	1.36M
Profits Per Employee	45,841
Employee Count	104,200
Asset Turnover	1.57
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -15.82% in the last 52 weeks. The beta is 0.78, so Elevance Health's price volatility has been lower than the market average.

Beta (5Y)	0.78
52-Week Price Change	-15.82%
50-Day Moving Average	414.13
200-Day Moving Average	451.11
Relative Strength Index (RSI)	49.12
Average Volume (20 Days)	1,233

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.59

Income Statement

In the last 12 months, Elevance Health had revenue of GBP 141.23 billion and earned 4.78 billion in profits. Earnings per share was 20.51.

Revenue	141.23B
Gross Profit	39.33B
Operating Income	7.35B
Pretax Income	6.31B
Net Income	4.78B
EBITDA	7.87B
EBIT	7.35B
Earnings Per Share (EPS)	20.51

Full Income Statement

Balance Sheet

The company has 27.70 billion in cash and 25.59 billion in debt, giving a net cash position of -18.97 billion.

Cash & Cash Equivalents	27.70B
Total Debt	25.59B
Net Cash	-18.97B
Net Cash Per Share	n/a
Equity (Book Value)	33.09B
Book Value Per Share	145.07
Working Capital	14.67B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 4.64 billion and capital expenditures -1.00 billion, giving a free cash flow of 3.64 billion.

Operating Cash Flow	4.64B
Capital Expenditures	-1.00B
Free Cash Flow	3.64B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 27.85%, with operating and profit margins of 5.20% and 3.38%.

Gross Margin	27.85%
Operating Margin	5.20%
Pretax Margin	4.47%
Profit Margin	3.38%
EBITDA Margin	5.57%
EBIT Margin	5.20%
FCF Margin	2.57%

Dividends & Yields

This stock pays an annual dividend of 5.13, which amounts to a dividend yield of 1.20%.

Dividend Per Share	5.13
Dividend Yield	1.20%
Dividend Growth (YoY)	6.61%
Years of Dividend Growth	7
Payout Ratio	25.22%
Buyback Yield	1.90%
Shareholder Yield	3.10%
Earnings Yield	6.59%
FCF Yield	5.02%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a